Autolus Therapeutics Delays Its First Quarter 2024 Earnings Release and Conference Call
Author: Benzinga Newsdesk | May 13, 2024 07:27am
The Company is canceling its previously announced earnings release and call scheduled for before U.S. market open on May 14, 2024. The Company expects to file the Q1 2024 10-Q as soon as practicable and no later
The Company is canceling its previously announced earnings release and call scheduled for before U.S. market open on May 14, 2024. The Company expects to file the Q1 2024 10-Q as soon as practicable and no later than the May 20, 2024
Posted In: AUTL